Micro-pharmacokinetics of lidocaine and bupivacaine transfer across a myelinated nerve fiber.


Journal

Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250

Informations de publication

Date de publication:
10 2023
Historique:
received: 14 04 2023
revised: 20 07 2023
accepted: 14 08 2023
medline: 27 9 2023
pubmed: 24 8 2023
entrez: 23 8 2023
Statut: ppublish

Résumé

The aim of the present study was to predict the time to onset and duration of action of two local anesthetics (lidocaine and bupivacaine) based on experimental dimensions of a typical nerve and experimental octanol/water partition coefficients. We began our compilation of experimental data with a numerical solution of the Smoluchowski equation for the transfer of lidocaine and bupivacaine across the axon membrane in the region of the node of Ranvier (axolemma) and across the Schwann cell. The difference between the aqueous and lipid environments of the neuron was simulated by including the coordinate-dependent chemical potential. In the second step, the permeation rates calculated using the diffusion equation were used to solve a system of four ordinary differential equations. This approach allowed us to simulate the cellular environment for a longer time and to compare our model with pharmacokinetic properties (time to onset and duration of action) of local anesthetics from the literature. The behavior of local anesthetics under physiological conditions and in case of local acidosis was also simulated. We demonstrated that local anesthetics cross the axolemma in a time span of less than 1 μs. The time to onset of action, controlled by diffusion from the epineurium to an axon with a typical distance of 500 μm, was 167 s and 186 s for lidocaine and bupivacaine, respectively. The calculated half-life, which is a measure of the duration of action, was 41 min and 328 min for lidocaine and bupivacaine, respectively. Duration of action is controlled by the storage capacity of lipophilic compartments around the axon, which is higher for bupivacaine but lower in local acidosis. For the latter case, the literature, including textbooks, provides a misinterpretation, namely that protonated species cannot penetrate the membrane.

Sections du résumé

BACKGROUND
The aim of the present study was to predict the time to onset and duration of action of two local anesthetics (lidocaine and bupivacaine) based on experimental dimensions of a typical nerve and experimental octanol/water partition coefficients.
METHODS
We began our compilation of experimental data with a numerical solution of the Smoluchowski equation for the transfer of lidocaine and bupivacaine across the axon membrane in the region of the node of Ranvier (axolemma) and across the Schwann cell. The difference between the aqueous and lipid environments of the neuron was simulated by including the coordinate-dependent chemical potential. In the second step, the permeation rates calculated using the diffusion equation were used to solve a system of four ordinary differential equations. This approach allowed us to simulate the cellular environment for a longer time and to compare our model with pharmacokinetic properties (time to onset and duration of action) of local anesthetics from the literature. The behavior of local anesthetics under physiological conditions and in case of local acidosis was also simulated.
RESULTS
We demonstrated that local anesthetics cross the axolemma in a time span of less than 1 μs. The time to onset of action, controlled by diffusion from the epineurium to an axon with a typical distance of 500 μm, was 167 s and 186 s for lidocaine and bupivacaine, respectively. The calculated half-life, which is a measure of the duration of action, was 41 min and 328 min for lidocaine and bupivacaine, respectively.
CONCLUSIONS
Duration of action is controlled by the storage capacity of lipophilic compartments around the axon, which is higher for bupivacaine but lower in local acidosis. For the latter case, the literature, including textbooks, provides a misinterpretation, namely that protonated species cannot penetrate the membrane.

Identifiants

pubmed: 37611421
pii: S0010-4825(23)00840-5
doi: 10.1016/j.compbiomed.2023.107375
pii:
doi:

Substances chimiques

Bupivacaine Y8335394RO
Lidocaine 98PI200987
Anesthetics, Local 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107375

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Vladimir Smrkolj (V)

Institute of Anatomy, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; Laboratory of Computational Biochemistry and Drug Design, National Institute of Chemistry, Ljubljana, Slovenia.

Domen Pregeljc (D)

Department of Chemistry, Imperial College London, London, United Kingdom.

Hana Kavčič (H)

Clinical Department for Anesthesiology and Surgical Intensive Therapy of University Medical Center Ljubljana, Ljubljana, Slovenia; Department of Anesthesiology and Reanimatology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Nejc Umek (N)

Institute of Anatomy, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Janez Mavri (J)

Laboratory of Computational Biochemistry and Drug Design, National Institute of Chemistry, Ljubljana, Slovenia. Electronic address: janez.mavri@ki.si.

Articles similaires

Humans Ropivacaine Dexmedetomidine Double-Blind Method Male

A clinical trial of ropivacaine in arthocentesis for TMD.

Laifeng Huang, Zeliu Huang, Shiyun Bi et al.
1.00
Humans Ropivacaine Temporomandibular Joint Disorders Anesthetics, Local Lidocaine

Classifications MeSH